Conference Highlights: IAS 2021
New research was presented at IAS 2021, the virtual 11th International AIDS Society Conference on...
FDA / Research
Covid-19: 1-in-4 U.S. Hospital Deaths Linked to Caseload Surges
Close to 6,000 early pandemic deaths may have been avoided, NIH study found Roughly 1-in-4 Covid-19 deaths in U.S. hospitals during the early months of the Covid-19 pandemic may have been attributable to strains on facilities...
Covid-19: 1-in-3 Patients Reported Long-Hauler Symptoms
Lingering fatigue, loss of taste and smell reported most often Close to a third of people who experienced mild to moderate Covid-19 symptoms during the acute phase of the illness had lingering symptoms 7 to 9 months later,...
Covid-19: CoronaVac Vaccine Highly Effective for Preventing Hospitalization, Death
Vaccine proved 66% effective for preventing disease in real-world study from Chile Real-world data...
New Research Finds J&J Vaccine Has Muscle Against Covid’s Delta Variant
The data is reassuring to people who got this shot.
Covid-19: HEPA Filters Plus Masks Substantially Reduce Viral Exposure
A viable solution for reducing Covid spread in close indoor settings? CDC researchers found that adding portable high efficiency particulate air (HEPA) cleaners to a universal masking strategy led to a dramatic reduction in...
Covid-19: Breakthrough Infections Involve Lower Viral Load Following mRNA Vaccination
Vaccinated people less likely to infect others, study findings suggest Partial or full vaccination with mRNA Covid-19 vaccine was associated with lower viral load among breakthrough cases, suggestive of reduced SARS-CoV-2...
Covid-19: Protein-Based Vax Safe, Highly Effective, Study Finds
Efficacy similar to that reported for mRNA vaccines Peer-reviewed findings from a phase III trial of the NVX-CoV2373 nanoparticle protein-based Covid-19 vaccine (Novavax) in the United Kingdom showed full vaccination to convey...
Covid-19: mRNA Vaccines Convey Long-Lasting Protection, Study Finds
Booster doses may not be needed by many for years, or ever, findings suggest New research offers some of the first direct evidence showing mRNA Covid-19 vaccines to convey long-term protection against severe illness related to...
Covid 19: Thrombosis After mRNA Vax Rare, But Possible
Authors detail a case of thrombosis with thrombocytopenia after mRNA-1273 vaccination Although thrombosis with thrombocytopenia has been reported after vaccination with adenovirus vector vaccines for Covid-19, researchers have...
Covid-19: New Reports of Vaccine Linked Myocarditis
Most cases were in younger males, and most were mild Two case reports describe acute myocarditis in adult, mostly male recipients, occurring within days of receiving mRNA Covid-19 vaccines.The new reports, published online June...
Post-COVID-19 Symptoms Are Common, Affecting 23.2 Percent
MONDAY, June 28, 2021 (HealthDay News) — Post-COVID-19 conditions are common among patients...
